Brand
NATCO Pharma Limited
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for NATCO Pharma Limited and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-04-17FDA-DrugClass IILansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
CGMP Deviations
- 2024-02-14FDA-DrugClass IILansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Get notified about new NATCO Pharma Limited recalls
Free weekly digest. We email when a new federal recall affects NATCO Pharma Limited or anything else in your household.
Get the Sunday Brief